NB. This article is not published yet. Please try again later.
More Popular Related Articles on Intellectual Property from USA
Frommer Lawrence & Haug LLP
As set forth in the decision, Mylan's failure to respond to a deficiency letter received from FDA in May 2014 "raise[d] serious questions in the Court's mind as to the viability of Mylan's ANDA product as currently formulated."
Stites & Harbison PLLC
GMW and Boogle got tangled up this week over trademarks, kind of. As you've likely heard, Google reorganized itself to create a holding company called Alphabet.
Foley & Lardner
Several lessons are apparent from a review of the first successful defense of the Orange Book listed pharmaceutical patents in Amneal v. Supernus.
Seyfarth Shaw LLP
In an attempt to provide further guidance and regulation in this area, since April 2012, a growing number of state legislatures in the United States have passed various forms of social media privacy legislation.
Fish & Richardson PC
Fed Cir affirms judgment upholding the PTO's patent term adjustment calculation. The patentee had filed its original application in 2002, yet the PTO did not take any action until 2006, when it issued a restriction requirement.
Fox Rothschild LLP
Navigating intellectual property protections and issues can be a complicated and challenging process for emerging companies.
Seyfarth Shaw LLP
We are pleased to announce the webinar "State Specific Non-Compete Oddities Employers Should Be Aware Of " is now available as a podcast and webinar recording.
Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
The Supreme Court recently declined to overturn its 1964 decision in Brulotte v. Thys Co., where it held that a patentee could not receive royalties for sales made after the patent at issue expired.